489 related articles for article (PubMed ID: 28215587)
1. Surface expression of Helicobacter pylori HpaA adhesion antigen on Vibrio cholerae, enhanced by co-expressed enterotoxigenic Escherichia coli fimbrial antigens.
Tobias J; Lebens M; Wai SN; Holmgren J; Svennerholm AM
Microb Pathog; 2017 Apr; 105():177-184. PubMed ID: 28215587
[TBL] [Abstract][Full Text] [Related]
2. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.
Tobias J; Lebens M; Bölin I; Wiklund G; Svennerholm AM
Vaccine; 2008 Feb; 26(6):743-52. PubMed ID: 18191006
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of major colonization factors of enterotoxigenic Escherichia coli, alone or together, on non-toxigenic E. coli bacteria.
Tobias J; Holmgren J; Hellman M; Nygren E; Lebens M; Svennerholm AM
Vaccine; 2010 Oct; 28(43):6977-84. PubMed ID: 20728524
[TBL] [Abstract][Full Text] [Related]
4. A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori.
Flach CF; Svensson N; Blomquist M; Ekman A; Raghavan S; Holmgren J
Vaccine; 2011 Feb; 29(6):1235-41. PubMed ID: 21147129
[TBL] [Abstract][Full Text] [Related]
5. Enterotoxigenic Escherichia coli Adhesin-Toxoid Multiepitope Fusion Antigen CFA/I/II/IV-3xSTa
Nandre R; Ruan X; Lu T; Duan Q; Sack D; Zhang W
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263112
[TBL] [Abstract][Full Text] [Related]
6. Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice.
Tobias J; Svennerholm AM; Carlin NI; Lebens M; Holmgren J
Vaccine; 2011 Nov; 29(48):8863-9. PubMed ID: 21983363
[TBL] [Abstract][Full Text] [Related]
7. Maternal vaccination with a fimbrial tip adhesin and passive protection of neonatal mice against lethal human enterotoxigenic Escherichia coli challenge.
Luiz WB; Rodrigues JF; Crabb JH; Savarino SJ; Ferreira LC
Infect Immun; 2015 Dec; 83(12):4555-64. PubMed ID: 26371126
[TBL] [Abstract][Full Text] [Related]
8. Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates.
Tobias J; Svennerholm AM
Appl Microbiol Biotechnol; 2012 Mar; 93(6):2291-300. PubMed ID: 22350259
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV
Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896
[TBL] [Abstract][Full Text] [Related]
10. Recombinant HpaA purified from Escherichia coli has biological properties similar to those of native Helicobacter pylori HpaA.
Lundstrom A; Bolin I; Bystrom M; Nystrom S
APMIS; 2003 Mar; 111(3):389-97. PubMed ID: 12752218
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background.
Sutton P; Doidge C; Pinczower G; Wilson J; Harbour S; Swierczak A; Lee A
FEMS Immunol Med Microbiol; 2007 Jul; 50(2):213-9. PubMed ID: 17567282
[TBL] [Abstract][Full Text] [Related]
12. Construction of a recombinant Lactococcus lactis strain expressing a fusion protein of Omp22 and HpaA from Helicobacter pylori for oral vaccine development.
Zhang R; Duan G; Shi Q; Chen S; Fan Q; Sun N; Xi Y
Biotechnol Lett; 2016 Nov; 38(11):1911-1916. PubMed ID: 27406731
[TBL] [Abstract][Full Text] [Related]
13. Construction and expression of immunogenic hybrid enterotoxigenic Escherichia coli CFA/I and CS2 colonization fimbriae for use in vaccines.
Tobias J; Svennerholm AM; Holmgren J; Lebens M
Appl Microbiol Biotechnol; 2010 Jul; 87(4):1355-65. PubMed ID: 20405124
[TBL] [Abstract][Full Text] [Related]
14. [Co-expression of CFA/I and CS6 of Enterotoxigenic Escherichia coli ( ETEC ) in Shigella flexneri 2a T32 Derivative Strain FWL01].
Zheng JP; Wang LC; Wang P; Luo G; Li SQ; Duan HQ; Huang CF; Zhang ZS
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Nov; 35(11):1005-10. PubMed ID: 14614538
[TBL] [Abstract][Full Text] [Related]
15. Assessment by electron-microscopy of recombinant Vibrio cholerae and Salmonella vaccine strains expressing enterotoxigenic Escherichia coli-specific surface antigens.
Ziethlow V; Favre D; Viret JF; Frey J; Stoffel MH
Clin Microbiol Infect; 2008 Mar; 14(3):282-6. PubMed ID: 18093230
[TBL] [Abstract][Full Text] [Related]
16. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses.
Nyström J; Svennerholm AM
Vaccine; 2007 Mar; 25(14):2591-8. PubMed ID: 17239498
[TBL] [Abstract][Full Text] [Related]
17. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
[TBL] [Abstract][Full Text] [Related]
18. Multiepitope fusion antigen induces broadly protective antibodies that prevent adherence of Escherichia coli strains expressing colonization factor antigen I (CFA/I), CFA/II, and CFA/IV.
Ruan X; Knudsen DE; Wollenberg KM; Sack DA; Zhang W
Clin Vaccine Immunol; 2014 Feb; 21(2):243-9. PubMed ID: 24351757
[TBL] [Abstract][Full Text] [Related]
19. In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae.
Ryan ET; Crean TI; John M; Butterton JR; Clements JD; Calderwood SB
Infect Immun; 1999 Apr; 67(4):1694-701. PubMed ID: 10085006
[TBL] [Abstract][Full Text] [Related]
20. The rOmp22-HpaA fusion protein confers protective immunity against helicobacter pylori in mice.
Huang X; Xu B; Duan G; Song C
Curr Microbiol; 2013 Oct; 67(4):487-92. PubMed ID: 23715666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]